MX2015003937A - Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant. - Google Patents
Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant.Info
- Publication number
- MX2015003937A MX2015003937A MX2015003937A MX2015003937A MX2015003937A MX 2015003937 A MX2015003937 A MX 2015003937A MX 2015003937 A MX2015003937 A MX 2015003937A MX 2015003937 A MX2015003937 A MX 2015003937A MX 2015003937 A MX2015003937 A MX 2015003937A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- inflammatory
- antihistaminic
- composition including
- immunosuppressant
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention refers to a pharmaceutical composition that contains an antihistaminic, anti-inflammatory glucocorticoid and pharmaceutically acceptable excipients or vehicles or a combination of an antihistaminic, anti-inflammatory-glucocorticoid, decongestant and pharmaceutically acceptable excipients or vehicles. The invention also refers to the use of said combination indicated for treating symptoms of nasal congestion, allergic and vasomotor rhinitis, acute rhinopharyngitis, asthma, hives and eyes and nose itching and a process for manufacturing said composition.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2015003937A MX2015003937A (en) | 2015-03-26 | 2015-03-26 | Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant. |
BR102016006254A BR102016006254A2 (en) | 2015-03-26 | 2016-03-22 | pharmaceutical combination of non-sedative antihistamine and anti-inflammatory immunosuppressant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2015003937A MX2015003937A (en) | 2015-03-26 | 2015-03-26 | Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015003937A true MX2015003937A (en) | 2016-09-26 |
Family
ID=57003228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015003937A MX2015003937A (en) | 2015-03-26 | 2015-03-26 | Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant. |
Country Status (2)
Country | Link |
---|---|
BR (1) | BR102016006254A2 (en) |
MX (1) | MX2015003937A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022023463A1 (en) * | 2020-07-30 | 2022-02-03 | Faes Farma, S.A. | Decongestant drug delivery system |
-
2015
- 2015-03-26 MX MX2015003937A patent/MX2015003937A/en unknown
-
2016
- 2016-03-22 BR BR102016006254A patent/BR102016006254A2/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022023463A1 (en) * | 2020-07-30 | 2022-02-03 | Faes Farma, S.A. | Decongestant drug delivery system |
Also Published As
Publication number | Publication date |
---|---|
BR102016006254A2 (en) | 2016-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018013472A (en) | Combination treatment of ocular inflammatory disorders and diseases. | |
SV2018005612A (en) | AGENTS, USES AND METHODS FOR THE TREATMENT OF SINUCLEINOPATIA | |
EP3377050A4 (en) | Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms | |
CL2019001293A1 (en) | Agents, uses and methods for the treatment of synucleinopathy. | |
PH12016501355A1 (en) | Bicyclic heterocyclic derivatives as bromodomain inhibitors | |
WO2014064410A3 (en) | Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane | |
WO2016005466A3 (en) | IMPROVED Aß PROTOFIBRIL BINDING ANTIBODIES | |
MX2017002374A (en) | Compositions and methods to treat vision disorders. | |
CU20190060A7 (en) | FORMS OF PHARMACEUTICAL ADMINISTRATION CONTAINING INHIBITORS OF TASK-1 AND TASK-3 CHANNELS HELPFUL IN THE TREATMENT OF RESPIRATORY DISORDERS | |
NZ705539A (en) | Treatment of post-traumatic stress disorder with isolated mycobacterium | |
MX2020012979A (en) | Methods for increasing sepiapterin plasma exposure. | |
CL2015000559A1 (en) | Compounds derived from 2-oxo-2,3-dihydro-indoles; its process of obtaining; pharmaceutical composition and combination that includes them; and its use for the treatment of CNS disorders that are positive or negative symptoms of schizophrenia, substance abuse, alcohol and drug addiction, Alzheimer's disease, Parkinson's disease, among others. | |
NZ744323A (en) | Compositions comprising 15-hepe and methods of using the same | |
IL286268A (en) | Pridopidine for use in the treatment of mitochondrial associated diseases and disorders, including symptoms thereof | |
MX2019006495A (en) | Treatment of neurological diseases. | |
EP3678671A4 (en) | Methods for treating sleep disorders, sleep disturbances, and related symptoms using aminosterol compositions | |
ZA202212128B (en) | Combination of alcaftadine and a corticosteroid | |
MX2021003862A (en) | Crystalline forms and processes of lenvatinib besylate. | |
CO2020002992A2 (en) | Pharmaceutical compositions containing anti-beta-amyloid antibodies | |
ZA201907101B (en) | Methods of preventing or treating ophthalmic diseases | |
MX2015003937A (en) | Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant. | |
CL2023002871A1 (en) | Nasal compositions comprising alcaftadine | |
EP3639854A4 (en) | Mtor-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof | |
WO2018098292A3 (en) | Methods for treating opioid addiction | |
WO2017142895A8 (en) | Compositions and methods for treating clostridium associated diseases |